The business of life sciences R&D is fundamentally shifting – from a focus on approval to a broader view on widespread adoption by providers and payers, from proving value in controlled, clinical settings to demonstrating it in target populations and real-world conditions. Gain insights into the patients that benefit from your products and learn how to distinguish who achieves significantly better outcomes than others. Employ AI-enriched profiles to define  precision cohorts and understand the medical and social factors that impact the patient journey and access to therapy.